journal article·2024-02Open access

Cucurbit[7]uril‐Mediated Organ‐Specific Delivery of Ultrasmall NIR‐II Luminescent Gold Nanocarriers for Therapy of Acute Kidney Injury

Kui He, Yuan‐Fu Ding, Zhipeng Zhao, Ben Liu, Wenyan Nie, Xiaoxi Luo, Hua‐Zhong Yu, Jinbin Liu, Ruibing Wang

Advanced Functional Materials· Volume 34· Issue 6

Abstract

Abstract The design of nanocarriers that selectively target the liver or kidney is a significant challenge in drug delivery due to the diverse physiological structures and inherent characteristics, as well as their distinct requirements for nanocarriers. Herein, a strategy to synthesize a series of second near‐infrared region (NIR‐II) emitting gold nanocarriers for fine‐tuning liver or kidney‐specific delivery via altering their surface chemistry using cucurbit[7]uril (CB[7]) and Cys‐Arg‐Gly‐Asp (CRGD) peptide is reported. Accordingly, it shows that ultrasmall nanocarriers can facilitate kidney‐targeted delivery in cisplatin‐induced acute kidney injury (AKI) mice, which significantly boosted the accumulation of dexamethasone (DXM) loaded onto the nanocarriers at the site of injured kidneys, thereby achieving improved therapeutic results. Thus, this organ‐specific delivery strategy holds tremendous promise for improving drug delivery efficiency and providing new perspectives and methods for personalized treatments.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanocluster Synthesis and Applications · Luminescence and Fluorescent Materials · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

State Key Laboratory of Quality Research in Chinese Medicine Institute of Chinese Medical Sciences University of Macau Taipa Macau SAR 999078 China

Key Laboratory of Functional Molecular Engineering of Guangdong Province School of Chemistry and Chemical Engineering South China University of Technology Guangzhou 510640 China

Department of Chemistry Simon Fraser University Burnaby British Columbia V5A 1S6 Canada

Funding

Basic and Applied Basic Research Foundation of Guangdong Province · Postdoctoral Research Foundation of China · Innovative Research Group Project of the National Natural Science Foundation of China

References (45)

Show source-provided references
1. 10.1038/s44222-022-00010-810.1038/s44222-022-00010-8 ↗
2. 10.1038/s41573-020-0090-810.1038/s41573-020-0090-8 ↗
3. 10.1002/anie.20220394210.1002/anie.202203942 ↗
4. 10.1038/s41563-019-0385-510.1038/s41563-019-0385-5 ↗
5. 10.1038/s41467-018-04763-y10.1038/s41467-018-04763-y ↗
6. 10.1038/s41467-020-20467-810.1038/s41467-020-20467-8 ↗
7. 10.1038/s41578-022-00529-710.1038/s41578-022-00529-7 ↗
8. 10.1021/acsnano.9b0138310.1021/acsnano.9b01383 ↗
9. 10.1016/j.cell.2020.02.00110.1016/j.cell.2020.02.001 ↗
10. 10.1038/s41565-020-0669-610.1038/s41565-020-0669-6 ↗
11. 10.1038/s41565-023-01366-710.1038/s41565-023-01366-7 ↗
12. 10.1021/acs.chemrev.0c0049510.1021/acs.chemrev.0c00495 ↗
13. 10.1002/adfm.20210566210.1002/adfm.202105662 ↗
14. 10.1038/s44222-022-00002-810.1038/s44222-022-00002-8 ↗
15. 10.1021/jacs.3c0288010.1021/jacs.3c02880 ↗
16. 10.1002/anie.20221472010.1002/anie.202214720 ↗
17. 10.1021/jacs.0c0044310.1021/jacs.0c00443 ↗
18. 10.1016/j.nantod.2019.10076710.1016/j.nantod.2019.100767 ↗
19. 10.1021/acs.analchem.2c0561210.1021/acs.analchem.2c05612 ↗
20. 10.1021/acs.chemrev.8b0072610.1021/acs.chemrev.8b00726 ↗
21. 10.1002/ange.20201087010.1002/ange.202010870 ↗
22. 10.1021/acsnano.9b0091110.1021/acsnano.9b00911 ↗
23. 10.1002/ange.20210160910.1002/ange.202101609 ↗
24. 10.1002/smll.20210248110.1002/smll.202102481 ↗
25. 10.1021/acsnano.0c0638810.1021/acsnano.0c06388 ↗
26. 10.1021/acsnano.2c0375210.1021/acsnano.2c03752 ↗
27. 10.1021/acs.chemrev.1c0105010.1021/acs.chemrev.1c01050 ↗
28. 10.1002/anie.20220676310.1002/anie.202206763 ↗
29. 10.31635/ccschem.020.20200028310.31635/ccschem.020.202000283 ↗
30. 10.1038/s41467-023-36057-310.1038/s41467-023-36057-3 ↗
31. 10.1021/acs.nanolett.2c0120310.1021/acs.nanolett.2c01203 ↗
32. 10.1002/ange.20191638010.1002/ange.201916380 ↗
33. 10.1021/jacs.2c0503610.1021/jacs.2c05036 ↗
34. 10.1021/jacs.7b0515410.1021/jacs.7b05154 ↗
35. 10.31635/ccschem.021.20210102910.31635/ccschem.021.202101029 ↗
36. 10.1016/j.carbpol.2022.11996810.1016/j.carbpol.2022.119968 ↗
37. 10.1002/ange.20130446510.1002/ange.201304465 ↗
38. 10.1002/smll.20120073310.1002/smll.201200733 ↗
39. 10.1681/ASN.201301001210.1681/ASN.2013010012 ↗
40. 10.1021/acs.molpharmaceut.0c0118210.1021/acs.molpharmaceut.0c01182 ↗
41. 10.1021/acs.accounts.2c0046210.1021/acs.accounts.2c00462 ↗
42. 10.1002/ange.20130963510.1002/ange.201309635 ↗
43. 10.1038/s41467-018-04161-410.1038/s41467-018-04161-4 ↗
44. 10.1038/s41581-022-00539-210.1038/s41581-022-00539-2 ↗
45. 10.1021/jacs.1c0889810.1021/jacs.1c08898 ↗